Details for New Drug Application (NDA): 202524
✉ Email this page to a colleague
The generic ingredient in LEVETIRACETAM is levetiracetam. There are thirty-five drug master file entries for this compound. Eighty-six suppliers are listed for this compound. Additional details are available on the levetiracetam profile page.
Summary for 202524
Tradename: | LEVETIRACETAM |
Applicant: | Rouses Point Pharms |
Ingredient: | levetiracetam |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 500MG | ||||
Approval Date: | Aug 27, 2012 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 750MG | ||||
Approval Date: | Aug 27, 2012 | TE: | RLD: | No |
Complete Access Available with Subscription